文献速递神经肿瘤

术中磁共振成像在初诊多形性胶质母细胞瘤切除术中的真实影响:单外科医生经验的观察性分析队列研究

Real Impact of Intraoperative Magnetic Resonance Imaging in Newly Diagnosed Glioblastoma Multiforme Resection: An Observational Analytic Cohort Study From a Single Surgeon Experience.
PubMed 文献 · World Neurosurg · 2018-01-06

该单外科医生观察性分析队列研究回顾性纳入2009年3月至2017年1月两所附属医院的129例胶质母细胞瘤患者,比较未使用术中磁共振的65例(A组)与使用术中磁共振的64例(B组)。B组平均切除程度、无进展生存期和总生存期均高于A组。作者认为1.5-T术中磁共振安全有效,可显著优化胶质瘤切除程度和患者生存。

要点

  • B组平均切除程度94.01%±7.42%高于A组86.23%±10.51%。
  • B组无进展生存期7.89±2.75个月长于A组5.38±2.32个月。
  • B组总生存期16.43±3.41个月长于A组13.38±4.06个月。

核心结论

  • 作者认为1.5-T术中磁共振是安全有效的技术,其使用可显著优化胶质瘤切除程度和患者生存。

研究设计与样本

  • 回顾性观察性分析队列研究,2009年3月至2017年1月在两所同属一所大学的附属医院纳入129例接受开颅肿瘤切除术的胶质母细胞瘤患者。
  • 比较未使用术中磁共振的65例(A组)与使用术中磁共振的64例(B组),所有手术均由同一名资深作者外科医生完成。
  • 采用钆增强T1加权成像进行切除程度体积分析。

主要发现

  • 平均切除程度从A组86.23%±10.51%增至B组94.01%±7.42%。
  • 无进展生存期A组5.38±2.32个月 vs B组7.89±2.75个月。
  • 总生存期A组13.38±4.06个月 vs B组16.43±3.41个月。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The goal of surgery for brain glioma is to maximize the extent of tumor resection, avoiding postoperative functional impairment. Intraoperative (Io) magnetic resonance imaging (MRI) has emerged as an effective tool to guide a safer glioma resection. The objective of this study is to assess the real impact of Io MRI in O-6-methylguanine-DNA methyltransferase and non-O-6-methylguanine-DNA methyltransferase methylated glioma surgery. METHODS: A total of 129 patients suffering glioblastoma who underwent craniotomy for tumor resection were retrospectively evaluated between March 2009 and January 2017 at 2 different affiliated hospitals of the same university. We compared a subgroup of 65 patients operated on without Io MRI (group A) with a second subgroup of 64 patients who underwent surgery with the aid of Io MRI (group B). Volumetric analyses of the extent of resection (EOR) were performed using gadolinium-enhanced T1-weighted imaging. All surgical procedures were performed by a single surgeon (the senior author). RESULTS: The average EOR increased from 86.23% ± 10.51% for group A to 94.01% ± 7.42% in patients included in group B. The secondary end points of this study were progression-free survival (PFS) and overall survival (OS). PFS was found to be 5.38 ± 2.32 months for group A versus 7.89 ± 2.75 months for group B. Regarding OS, the average value was 13.38 ± 4.06 months for group A versus 16.43 ± 3.41 months for group B. CONCLUSIONS: We can affirm that 1.5-T Io MRI is a safe and effective technique, and its use optimizes significantly both the extent of glioma resection and the survival of patients.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Familiari P, Frati A, Pesce A, et al. Real Impact of Intraoperative Magnetic Resonance Imaging in Newly Diagnosed Glioblastoma Multiforme Resection: An Observational Analytic Cohort Study From a Single Surgeon Experience. World Neurosurg. 2018. PMID: 29309978. doi:10.1016/j.wneu.2017.12.176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。